A new swab test in the UK, called the WID-easy test, could significantly reduce the need for invasive procedures in women with abnormal uterine bleeding. Around 800,000 women seek medical advice for this issue each year, often undergoing painful tests. The WID-easy test is as accurate as traditional ultrasound scans and decreases false positives by 87%. Developed by Martin Widschwendter, this innovative test analyzes vaginal swabs for DNA methylation patterns, indicating the presence of womb cancer, with measures already in use across various medical facilities in the UK and Europe.
The WID-easy test is the first of its kind in the UK, using a simple swab method to detect womb cancer, providing a less invasive screening alternative.
Diagnostic procedures for uterine bleeding can be distressing; however, the new swab test detects womb cancer with accuracy comparable to ultrasounds while significantly reducing false positives.
Womb cancer diagnosis has risen sharply by 60% since the 1990s, making the development of convenient and effective screening methods like the WID-easy test increasingly vital.
Using DNA methylation patterns specific to cancer cells, the WID-easy test offers a modern and efficient approach to identifying womb cancer in women over 45.
Collection
[
|
...
]